Tricyclodecane-9-yl-xanthogenate
Showing 1 - 25 of 5,603
Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in New
Active, not recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +4 more
- Falimarev
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 4, 2022
Advanced Solid Tumor Trial in Guangzhou (YL-17231)
Recruiting
- Advanced Solid Tumor
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 5, 2023
YL-1 Needle Puncture vs BHC With Postoperative Exhaustive
Not yet recruiting
- Chronic Subdural Hematoma
- Burr Hole Craniostomy and Postoperative Exhaustive Drainage Strategy
- YL-1 puncture needle and Postoperative Exhaustive Drainage Strategy
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Oct 5, 2023
ALS Trial ([11C]CPPC PET ligand)
Not yet recruiting
- ALS
- [11C]CPPC PET ligand
- (no location specified)
Jan 9, 2023
Amyotrophic Lateral Sclerosis Trial in Baltimore ([11C]CPPC Injection)
Recruiting
- Amyotrophic Lateral Sclerosis
- [11C]CPPC Injection
-
Baltimore, MarylandJohns Hopkins Outpatient Center
Jul 11, 2022
Advanced Solid Tumors Trial in Shanghai (YL-13027)
Recruiting
- Advanced Solid Tumors
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Nov 15, 2021
Advanced Solid Tumors Trial in Shanghai (YL-13027,Sintilimab)
Not yet recruiting
- Advanced Solid Tumors
-
Shanghai, Shanghai, ChinaHuashan Hospital Affiliated to Fudan University
Jul 12, 2022
Gerontechnology Evaluation Framework: Outcome Validation
Not yet recruiting
- Technology
- Doing questionnaire
-
Hong Kong, Hong KongThe University of Hong Kong
Nov 24, 2023
Tobacco Use Disorder, Tobacco Smoking Trial in Baltimore ([F18]-ASEM
Recruiting
- Tobacco Use Disorder
- Tobacco Smoking
- [F18]-ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-[18F]fluorodibenzo[b,d]thiophene 5,5-dioxide)
- Contingency Management
-
Baltimore, MarylandJohns Hopkins Behavioral Pharmacology Research Unit
Jun 7, 2022
Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Active, not recruiting
- Human Papillomavirus Infection
- Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
- GARDASIL® 9
-
Kunming, Yunnan, ChinaYunnan Center for Disease Prevention and Control
Dec 23, 2022
Immunosuppressants to Postoperative Infection and Death
Recruiting
- Organ Transplantation
- +2 more
- Immunosuppressive Agents
-
Taichung, TaiwanChung Shan Medical University
Nov 6, 2023
Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)
Not yet recruiting
- Human Papillomavirus-Related Carcinoma
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +4 more
Aug 9, 2023
Hypoxia-induced Autophagy in the Pathogenesis of MAP
Not yet recruiting
- Hypoxia
- +3 more
- HIF 1α and LC3B expression and MMP-9 level
- (no location specified)
Apr 5, 2023
Diffuse Large B Cell Lymphoma Trial (anti-CD19 CAR NK cells)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- anti-CD19 CAR NK cells
- (no location specified)
Dec 21, 2022
Pancreatic Cancer Using CA19-9 and Fecal Elastase
Active, not recruiting
- Paancreatic Cancer
-
Seoul, Korea, Republic ofGangnam Severance Hospital
Jun 27, 2023
Cervical Cancer, Genital Wart, CIN Trial in Nanning (Zerun HPV-9, GARDASIL ®9)
Active, not recruiting
- Cervical Cancer
- +4 more
- Zerun HPV-9
- GARDASIL ®9
-
Nanning, Guangxi, ChinaGuangXi Center for Diseases Control and Prevention
Oct 26, 2022
Retinitis Pigmentosa Trial in Tel Hashomer (Alga Dunaliella Bardawil, Placebo (starch))
Active, not recruiting
- Retinitis Pigmentosa
- Alga Dunaliella Bardawil
- Placebo (starch)
-
Tel Hashomer, IsraelSheba Medical Center
Jan 15, 2023
Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)
Not yet recruiting
- Pancreatic Adenocarcinoma
- mFOLFIRINOX plus radiotherapy
- (no location specified)
Nov 21, 2023
Medication Use Among American Indians Adults
Withdrawn
- Type 2 Diabetes
- Medication Adherence
- (no location specified)
Sep 29, 2023
Postpartum Depression Trial in New York (Engage & Connect)
Recruiting
- Postpartum Depression
- Engage & Connect
-
New York, New YorkWeill Cornell Medicine
Nov 7, 2022
Post-traumatic Stress Disorder, Cocaine Use Disorder Trial in Zürich (Imagery, Minocycline, Placebo)
Recruiting
- Post-traumatic Stress Disorder
- Cocaine Use Disorder
- Imagery
- +2 more
-
Zürich, SwitzerlandPsychiatric University Hospital Zurich, University of Zurich
Jun 5, 2023
MDD Trial in Providence (EMA Monitoring, Scheduling Maintenance TMS sessions)
Recruiting
- Major Depressive Disorder
- EMA Monitoring
- Scheduling Maintenance TMS sessions
-
Providence, Rhode IslandButler Hospital
Nov 28, 2023
HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir
Not yet recruiting
- HIV
- Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
- Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
- (no location specified)
Nov 13, 2023